Venker Eric
- SEC CIK
- 0001801917
在各公司的最新職務
- ROIV Roivant Sciences Ltd.President & Immunovant CEO2026/9/1 申報
- IMVT Immunovant, Inc.執行長2026/7/6 申報
交易紀錄
所有把 Venker Eric 列為申報人的 Form 4，包括與他人共同申報的。每一列是一份申報裡同一種交易的合計；預設只顯示公開市場買進（P）與賣出（S）。
| 公司 | 申報時間（美東） | 交易日 | 內部人 | 交易 | 股數 | 均價 | 金額 | 交易後持股 | 持股變化 | 申報 |
|---|---|---|---|---|---|---|---|---|---|---|
| ROIVRoivant Sciences Ltd. | 2026/9/121:00 ET | 2026/8/28 | Venker EricPresident & Immunovant CEO | S賣出Common Shares | −20 萬 | $35.767 | −$715.34 萬 | 159.92 萬 | −11.1% | SEC10b5-1 |
| ROIVRoivant Sciences Ltd. | 2026/7/2921:00 ET | 2026/7/27 | Venker EricPresident & Immunovant CEO | S賣出Common Shares | −20 萬 | $34.95 | −$699 萬 | 161.31 萬 | −11.0% | SEC10b5-1 |
| IMVTImmunovant, Inc. | 2026/7/617:01 ET | 2026/7/2 | Venker Eric執行長 | S賣出Common Stock | −3,092 | $38.48 | −$11.9 萬 | 25.43 萬 | −1.2% | SEC |
| ROIVRoivant Sciences Ltd. | 2026/6/26 | 2026/6/24 | Venker EricPresident & Immunovant CEO | S賣出Common Shares | −20 萬 | $33.1563 | −$663.13 萬 | 161.31 萬 | −11.0% | SEC10b5-1 |
| ROIVRoivant Sciences Ltd. | 2026/5/22 | 2026/5/22 | Venker EricPresident & Immunovant CEO | S賣出Common Shares | −20 萬 | $30.27 | −$605.4 萬 | 161.31 萬 | −11.0% | SEC10b5-1 |
| ROIVRoivant Sciences Ltd. | 2026/4/22 | 2026/4/20 | Venker EricPresident & Immunovant CEO | S賣出Common Shares | −20 萬 | $29.59 | −$591.8 萬 | 164.75 萬 | −10.8% | SEC10b5-1 |
| IMVTImmunovant, Inc. | 2026/4/3 | 2026/4/2 | Venker Eric執行長 | S賣出Common Stock | −1.42 萬 | $24.0955 | −$34.29 萬 | 1.96 萬 | −42.1% | SEC |
| ROIVRoivant Sciences Ltd. | 2026/3/19 | 2026/3/17 | Venker EricPresident & Immunovant CEO | S賣出Common Shares | −20 萬 | $28.24 | −$564.8 萬 | 164.75 萬 | −10.8% | SEC10b5-1 |
| ROIVRoivant Sciences Ltd. | 2026/2/18 | 2026/2/13 | Venker EricPresident & Immunovant CEO | S賣出Common Shares | −20 萬 | $26.49 | −$529.8 萬 | 165.46 萬 | −10.8% | SEC10b5-1 |
| ROIVRoivant Sciences Ltd. | 2026/1/14 | 2026/1/12 | Venker EricPresident & Immunovant CEO | S賣出Common Shares | −20 萬 | $21.92 | −$438.4 萬 | 165.46 萬 | −10.8% | SEC10b5-1 |
| ROIVRoivant Sciences Ltd. | 2025/12/29 | 2025/12/23–12/24 | Venker EricPresident & Immunovant CEO | S賣出Common Shares | −27.5 萬 | $22.4718 | −$617.98 萬 | 165.46 萬 | −14.3% | SEC |
| ROIVRoivant Sciences Ltd. | 2025/12/11 | 2025/12/9 | Venker EricPresident & Immunovant CEO | S賣出Common Shares | −20 萬 | $20.85 | −$417 萬 | 149.79 萬 | −11.8% | SEC10b5-1 |
| ROIVRoivant Sciences Ltd. | 2025/11/7 | 2025/11/7 | Venker EricPresident & Immunovant CEO | S賣出Common Shares | −20 萬 | $20.22 | −$404.4 萬 | 150.5 萬 | −11.7% | SEC10b5-1 |
| ROIVRoivant Sciences Ltd. | 2025/10/17 | 2025/10/15–10/17 | Venker EricPresident & Immunovant CEO | S賣出Common Shares | −85.14 萬 | $16.9929 | −$1,446.75 萬 | 150.5 萬 | −36.1% | SEC10b5-1 |
| ROIVRoivant Sciences Ltd. | 2025/10/14 | 2025/10/9–10/13 | Venker EricPresident & Immunovant CEO | S賣出Common Shares | −12.57 萬 | $16.2918 | −$204.73 萬 | 150.5 萬 | −7.7% | SEC10b5-1 |
| ROIVRoivant Sciences Ltd. | 2025/10/8 | 2025/10/6–10/8 | Venker EricPresident & Immunovant CEO | S賣出Common Shares | −66.52 萬 | $16.2094 | −$1,078.18 萬 | 150.5 萬 | −30.7% | SEC10b5-1 |
| ROIVRoivant Sciences Ltd. | 2025/9/23 | 2025/9/19–9/23 | Venker EricPresident & Immunovant CEO | S賣出Common Shares | −171.1 萬 | $14.918 | −$2,552.48 萬 | 150.5 萬 | −53.2% | SEC10b5-1 |
| ROIVRoivant Sciences Ltd. | 2025/8/22 | 2025/8/20 | Venker EricPresident & Immunovant CEO | S賣出Common Shares | −10 萬 | $11.72 | −$117.2 萬 | 165.36 萬 | −5.7% | SEC10b5-1 |
| ROIVRoivant Sciences Ltd. | 2025/7/23 | 2025/7/21 | Venker EricPresident & Immunovant CEO | S賣出Common Shares | −10 萬 | $11.52 | −$115.2 萬 | 146.22 萬 | −6.4% | SEC10b5-1 |
| ROIVRoivant Sciences Ltd. | 2025/6/24 | 2025/6/20 | Venker Eric總裁、營運長 | S賣出Common Shares | −10 萬 | $11.45 | −$114.5 萬 | 146.22 萬 | −6.4% | SEC10b5-1 |
| ROIVRoivant Sciences Ltd. | 2025/6/4 | 2025/6/2–6/3 | Venker Eric總裁、營運長 | S賣出Common Shares | −100 萬 | $11.1549 | −$1,115.49 萬 | 146.22 萬 | −40.6% | SEC |
| ROIVRoivant Sciences Ltd. | 2025/5/22 | 2025/5/20 | Venker Eric總裁、營運長 | S賣出Common Shares | −10 萬 | $10.95 | −$109.5 萬 | 107.72 萬 | −8.5% | SEC10b5-1 |
| ROIVRoivant Sciences Ltd. | 2025/4/22 | 2025/4/21 | Venker Eric總裁、營運長 | S賣出Common Shares | −10 萬 | $10.22 | −$102.2 萬 | 111.63 萬 | −8.2% | SEC10b5-1 |
| ROIVRoivant Sciences Ltd. | 2025/3/24 | 2025/3/20–3/24 | Venker Eric總裁、營運長 | S賣出Common Shares | −75 萬 | $10.921 | −$819.07 萬 | 112.73 萬 | −40.0% | SEC10b5-1 |
| ROIVRoivant Sciences Ltd. | 2025/2/24 | 2025/2/20 | Venker Eric總裁、營運長 | S賣出Common Shares | −10 萬 | $10.65 | −$106.5 萬 | 89.69 萬 | −10.0% | SEC |
| ROIVRoivant Sciences Ltd. | 2025/2/14 | 2025/2/12–2/13 | Venker Eric總裁、營運長 | S賣出Common Shares | −43.54 萬 | $10.4749 | −$456.1 萬 | 89.69 萬 | −32.7% | SEC |
| ROIVRoivant Sciences Ltd. | 2025/1/22 | 2025/1/21 | Venker Eric總裁、營運長 | S賣出Common Shares | −10 萬 | $11.28 | −$112.8 萬 | 73.23 萬 | −12.0% | SEC10b5-1 |
| ROIVRoivant Sciences Ltd. | 2024/12/31 | 2024/12/27–12/30 | Venker Eric總裁、營運長 | S賣出Common Shares | −35.46 萬 | $11.6797 | −$414.17 萬 | 74.1 萬 | −32.4% | SEC |
| ROIVRoivant Sciences Ltd. | 2024/12/26 | 2024/12/20 | Venker Eric總裁、營運長 | S賣出Common Shares | −10 萬 | $11.49 | −$114.9 萬 | 59.56 萬 | −14.4% | SEC10b5-1 |
| ROIVRoivant Sciences Ltd. | 2024/11/22 | 2024/11/20 | Venker Eric總裁、營運長 | S賣出Common Shares | −10 萬 | $11.32 | −$113.2 萬 | 60.65 萬 | −14.2% | SEC10b5-1 |
| ROIVRoivant Sciences Ltd. | 2024/10/22 | 2024/10/21 | Venker Eric總裁、營運長 | S賣出Common Shares | −10 萬 | $11.65 | −$116.5 萬 | 61.75 萬 | −13.9% | SEC |
| ROIVRoivant Sciences Ltd. | 2024/2/9 | 2024/2/9 | Venker Eric總裁、營運長 | S賣出Common Shares | −9.7 萬 | $10.92 | −$105.87 萬 | 53.22 萬 | −15.4% | SEC10b5-1 |
| ROIVRoivant Sciences Ltd. | 2023/10/4 | 2023/10/2–10/5 | Venker Eric營運長 | S賣出Common Shares | −120 萬 | $10.4342 | −$1,252.1 萬 | 59.54 萬 | −66.8% | SEC10b5-1 |
| ROIVRoivant Sciences Ltd. | 2023/9/29 | 2023/9/27 | Venker Eric總裁、營運長 | S賣出Common Shares | −50 萬 | $13.02 | −$651 萬 | 59.54 萬 | −45.6% | SEC |
| ROIVRoivant Sciences Ltd. | 2023/9/12 | 2023/9/8 | Venker Eric營運長 | S賣出Common Shares | −10.64 萬 | $12.19 | −$129.74 萬 | 61.18 萬 | −14.8% | SEC |
| ROIVRoivant Sciences Ltd. | 2023/9/6 | 2023/9/1–9/6 | Venker Eric營運長 | S賣出Common Shares | −9.4 萬 | $11.9124 | −$111.93 萬 | 61.18 萬 | −13.3% | SEC |
| ROIVRoivant Sciences Ltd. | 2023/8/16 | 2023/8/14 | Venker Eric營運長 | S賣出Common Shares | −5.98 萬 | $11.89 | −$71.12 萬 | 62.79 萬 | −8.7% | SEC |
| ROIVRoivant Sciences Ltd. | 2023/8/7 | 2023/8/3 | Venker Eric營運長 | S賣出Common Shares | −4.46 萬 | $11.93 | −$53.24 萬 | 62.79 萬 | −6.6% | SEC |
| ROIVRoivant Sciences Ltd. | 2023/8/2 | 2023/7/31–8/2 | Venker Eric營運長 | S賣出Common Shares | −19.52 萬 | $11.9089 | −$232.42 萬 | 62.79 萬 | −23.7% | SEC |
| ROIVRoivant Sciences Ltd. | 2023/7/27 | 2023/7/25–7/27 | Venker Eric營運長 | S賣出Common Shares | −12.55 萬 | $10.9119 | −$136.98 萬 | 62.79 萬 | −16.7% | SEC |
| ROIVRoivant Sciences Ltd. | 2023/7/24 | 2023/7/20–7/24 | Venker Eric總裁、營運長 | S賣出Common Shares | −37.45 萬 | $11.1889 | −$418.99 萬 | 64.42 萬 | −36.8% | SEC |
| ROIVRoivant Sciences Ltd. | 2023/6/9 | 2023/6/7–6/9 | Venker Eric總裁、營運長 | S賣出Common Shares | −29.96 萬 | $9.91 | −$296.89 萬 | 66.01 萬 | −31.2% | SEC |
| ROIVRoivant Sciences Ltd. | 2023/5/25 | 2023/5/23 | Venker Eric總裁、營運長 | S賣出Common Shares | −415 | $9.85 | −$4,087.75 | 67.58 萬 | −0.1% | SEC |
| ROIVRoivant Sciences Ltd. | 2023/5/11 | 2023/5/9 | Venker Eric總裁、營運長 | S賣出Common Shares | −23.87 萬 | $9.23 | −$220.34 萬 | 67.58 萬 | −26.1% | SEC |
| ROIVRoivant Sciences Ltd. | 2023/5/8 | 2023/5/4–5/8 | Venker Eric總裁、營運長 | S賣出Common Shares | −15 萬 | $8.557 | −$128.39 萬 | 67.58 萬 | −18.2% | SEC10b5-1 |
| ROIVRoivant Sciences Ltd. | 2023/5/3 | 2023/5/1–5/3 | Venker Eric總裁、營運長 | S賣出Common Shares | −28.9 萬 | $8.3987 | −$242.71 萬 | 67.58 萬 | −30.0% | SEC10b5-1 |
| ROIVRoivant Sciences Ltd. | 2023/4/28 | 2023/4/26–4/28 | Venker Eric總裁、營運長 | S賣出Common Shares | −22.22 萬 | $8.5456 | −$189.92 萬 | 67.58 萬 | −24.7% | SEC10b5-1 |
| ROIVRoivant Sciences Ltd. | 2023/1/6 | 2023/1/5 | Venker Eric總裁、營運長 | S賣出Common Shares | −2.4 萬 | $8.02 | −$19.28 萬 | 72.94 萬 | −3.2% | SEC |
| ROIVRoivant Sciences Ltd. | 2023/1/4 | 2022/12/30 – 2023/1/3 | Venker Eric總裁、營運長 | S賣出Common Shares | −11.92 萬 | $7.4555 | −$88.9 萬 | 75.35 萬 | −13.7% | SEC |
| ROIVRoivant Sciences Ltd. | 2022/12/9 | 2022/12/8–12/9 | Venker Eric總裁、營運長 | S賣出Common Shares | −14.51 萬 | $7.0276 | −$101.97 萬 | 88.87 萬 | −14.0% | SEC |